“…Duarte I et al 3 present 19 patients with glomerular disease treated with RTX, retrospectively analyzed and with two different protocols of posology. Four of the 19 patients had FSGS, one of whom was considered steroid-resistant, whereas two patients both of whom were not steroid-resistant responded to the use of RTX.…”